Lorvotuzumab (anti-CD56)

Request For Quotation
Lorvotuzumab (anti-CD56) Suppliers list
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Beijing Jin Ming Biotechnology Co., Ltd.  
Tel: 010-60605840
Email: psaitong@jm-bio.com
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Company Name: Wuhan Acumen Bio-Technology Co.,ltd  
Tel: 027-027-16602739303 16602739303
Email: 673003916@qq.com

Lorvotuzumab (anti-CD56) manufacturers

  • Lorvotuzumab
  • Lorvotuzumab pictures
  • $313.00
  • 2026-09-10
  • CAS:339306-30-8
  • Purity: > 95%
  • Supply Ability: 10g
Lorvotuzumab (anti-CD56) Basic information
Product Name:Lorvotuzumab (anti-CD56)
Synonyms:Lorvotuzumab (anti-CD56);lorvotuzumab
CAS:339306-30-8
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Lorvotuzumab (anti-CD56) Structure
Lorvotuzumab (anti-CD56) Chemical Properties
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Lorvotuzumab (anti-CD56) Usage And Synthesis
UsesLorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1].
References[1] James I Geller, et al. ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study. Cancer. 2020 Dec 15;126(24):5303-5310. DOI:10.1002/cncr.33195
Lorvotuzumab (anti-CD56) Preparation Products And Raw materials
Tag:Lorvotuzumab (anti-CD56)(339306-30-8) Related Product Information
Brentuximab Vandortuzumab Vedotin Cofetuzumab Research Grade Inotuzumabc (DHD38502) Inebilizumab Belantamab